Rezultaty - Logie, Armelle

A pharmacokinetic–pharmacodynamic model predicting tumour growth inhibition after intermittent administration with the mTOR kinase inhibitor AZD8055 od Yates, James W T, Holt, Sarah V, Logie, Armelle, Payne, Kirsty, Woods, Karen, Wilkinson, Robert W, Davies, Barry R, Guichard, Sylvie M

Dokumenty pełnotekstowe Dokumenty pełnotekstowe Dokumenty pełnotekstowe

Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkers od Bradford, James R., Wappett, Mark, Beran, Garry, Logie, Armelle, Delpuech, Oona, Brown, Henry, Boros, Joanna, Camp, Nicola J., McEwen, Robert, Mazzola, Anne Marie, D'Cruz, Celina, Barry, Simon T.

Dokumenty pełnotekstowe Dokumenty pełnotekstowe Dokumenty pełnotekstowe

Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt’s lymphoma anti-tumor activity od Curtis, Nicola J., Mooney, Lorraine, Hopcroft, Lorna, Michopoulos, Filippos, Whalley, Nichola, Zhong, Haihong, Murray, Clare, Logie, Armelle, Revill, Mitchell, Byth, Kate F., Benjamin, Amanda D., Firth, Mike A., Green, Stephen, Smith, Paul D., Critchlow, Susan E.

Dokumenty pełnotekstowe Dokumenty pełnotekstowe Dokumenty pełnotekstowe

Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530 od Green, Tim P., Fennell, Mike, Whittaker, Robin, Curwen, Jon, Jacobs, Vivien, Allen, Jack, Logie, Armelle, Hargreaves, Judith, Hickinson, D. Mark, Wilkinson, Robert W., Elvin, Paul, Boyer, Brigitte, Carragher, Neil, Plé, Patrick A., Bermingham, Alun, Holdgate, Geoffrey A., Ward, Walter H.J., Hennequin, Laurent F., Davies, Barry R., Costello, Gerard F.

Dokumenty pełnotekstowe Dokumenty pełnotekstowe Dokumenty pełnotekstowe